IPV stands for inactivated poliovirus vaccine, a shot that protects against polio by using killed versions of the virus. Unlike the oral polio vaccine (OPV) that many countries used for decades, IPV cannot cause infection because the virus in it is completely inactive. It is the only polio vaccine used in the United States and is given as a four-dose series starting in infancy.
How IPV Works
The vaccine contains killed forms of all three types of poliovirus (types 1, 2, and 3). When injected, these inactive viral particles trigger your immune system to build antibodies without any risk of the virus replicating or causing disease. The immune response is strong in the bloodstream, which prevents the virus from reaching the spinal cord and brain where it causes paralysis.
One trade-off compared to the oral vaccine: IPV produces limited immunity in the lining of the gut. That means a vaccinated person is well protected from paralysis, but in theory could still briefly carry and shed the virus through stool after exposure. In countries still working to eliminate polio, this distinction matters for public health strategy. For individual protection against paralytic disease, IPV is highly effective.
Effectiveness
IPV produces immune protection in over 95% of recipients after just two doses. In clinical trials, seroconversion rates (the percentage of people who develop protective antibodies) reached 99 to 100% for all three poliovirus types after a full series. These numbers hold across both two-dose and three-dose schedules, though the standard U.S. recommendation is four doses to ensure long-lasting protection through childhood.
The Recommended Schedule
Children in the U.S. receive four doses of IPV:
- First dose: 2 months old
- Second dose: 4 months old
- Third dose: 6 through 18 months old
- Fourth dose: 4 through 6 years old
The vaccine is given as an injection, either into muscle or under the skin. For infants, the shot typically goes into the thigh. Older children and adults receive it in the upper arm. IPV is often bundled into combination vaccines, so your child may receive it alongside protection against other diseases in a single shot.
Why IPV Replaced the Oral Vaccine in the U.S.
The oral polio vaccine uses a live, weakened virus. While extremely effective at building gut immunity and easier to administer (just drops in the mouth), OPV carries a rare but real risk: in roughly 1 in every 2.4 million doses, the weakened virus can mutate back into a form that causes paralysis. This is called vaccine-associated paralytic polio, or VAPP.
Because IPV uses a completely killed virus, this risk is zero. The U.S. switched exclusively to IPV in 2000, once domestic polio was eliminated and the tiny risk from OPV was no longer justified. Many other high-income countries have done the same. In regions still fighting active polio transmission, some programs use a dose of IPV before starting OPV, which reduces the VAPP risk.
Side Effects
IPV is one of the milder vaccines in terms of side effects. The most common reaction is soreness at the injection site, reported by about 14 to 29% of recipients in clinical trials. Some studies also noted mild swelling at the injection site in about 18% of participants and redness in about 3%. These local reactions typically resolve within 48 hours.
Systemic reactions like low-grade fever, irritability, sleepiness, and fussiness can occur, particularly in infants, but tend to be mild and short-lived. When IPV is given alongside other childhood vaccines at the same visit, it does not increase the frequency or severity of side effects from those other vaccines. No serious adverse events have been causally linked to the current IPV formulation.
Who Should Not Get IPV
There are only two firm reasons to avoid the vaccine: a severe allergic reaction (anaphylaxis) to a previous dose or to any component in the vaccine, and pregnancy. If you or your child has a moderate or severe illness with or without fever, it’s generally recommended to wait until recovery before getting the shot. Mild illness, like a common cold, is not a reason to delay.
Why Polio Vaccination Still Matters
Polio has been eliminated from most of the world, but it has not been eradicated. Wild poliovirus type 1 still circulates in Pakistan, with cases reported as recently as early 2026. Outbreaks of vaccine-derived poliovirus (from mutated oral vaccine strains) continue to surface in parts of Africa, including the Democratic Republic of the Congo, Somalia, and Sudan.
Because the virus can travel with infected individuals across borders, unvaccinated people remain at risk even in countries that haven’t seen a case in decades. The four-dose IPV series remains one of the most straightforward ways to ensure lifelong protection against a disease that, when it strikes, can cause irreversible paralysis within hours.